The efficacy and safety of paclitaxel plus bevacizumab therapy in breast cancer patients with visceral crisis

BACKGROUND: Visceral crisis in metastatic breast cancer (MBC) is defined as severe organ dysfunction requiring rapidly efficacious therapy. Although weekly paclitaxel plus bevacizumab (wPTX + BV) achieves a high response rate in human epidermal growth factor receptor 2 (HER2)-negative MBC, the effic...

Descripción completa

Detalles Bibliográficos
Autores principales: Funasaka, Chikako, Naito, Yoichi, Kusuhara, Shota, Nakao, Takehiro, Fukasawa, Yoko, Mamishin, Kanako, Komuro, Ayumi, Okunaka, Mashiro, Kondoh, Chihiro, Harano, Kenichi, Kogawa, Takahiro, Matsubara, Nobuaki, Hosono, Ako, Kawasaki, Toshikatsu, Mukohara, Toru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095047/
https://www.ncbi.nlm.nih.gov/pubmed/33901922
http://dx.doi.org/10.1016/j.breast.2021.04.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095047/
https://www.ncbi.nlm.nih.gov/pubmed/33901922
http://dx.doi.org/10.1016/j.breast.2021.04.001

Ejemplares similares